BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1001555)

  • 21. Anti-H-2Dd antibodies cross-react with HLA--A11 and Aw31.
    Iványi P; van den Berg-Loonen E; de Greeve P
    Tissue Antigens; 1978 May; 11(5):439-42. PubMed ID: 694908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cytotoxicity of sera against brain and spinal cord antigens in relation to lymphocytes of varying origin].
    Belokrylov GA; Zhitmukhin IuL; Sofronov BN
    Biull Eksp Biol Med; 1976 Aug; 82(8):968-70. PubMed ID: 1026300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Specificity and effectiveness of HL-A sera from the firms Behringwerke and Biotest-Serum-Institut].
    Májský A
    Cesk Farm; 1975 Jul; 24(6):259-61. PubMed ID: 52412
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluation of rosette inhibition test by antisera to hl-a system.
    Laurentaci G; Favoino B
    Boll Ist Sieroter Milan; 1975 Jun; 54(2):136-9. PubMed ID: 1203080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interference between anti-HLA antibodies and adrenergic receptor-binding drugs.
    Scorza-Smeraldi R; Smeraldi E; Fabio G; Bellodi L; Sacchetti E; Rugarli C
    Tissue Antigens; 1977 Mar; 9(3):163-6. PubMed ID: 67655
    [No Abstract]   [Full Text] [Related]  

  • 26. Enhancement of reactivity of HLA-Cw antisera by extending the incubation time.
    Wong DM; Kumar R; Mittal KK
    Acta Anthropogenet; 1983; 7(3):197-203. PubMed ID: 6335043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Private and public specificities of the major murine histocompatibility complex (H-2): molecular representation of H-2Dd antigens.
    Hess M
    Folia Biol (Praha); 1975; 21(6):420-3. PubMed ID: 1204889
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunofluorescence of HL-A antigens in kidney tissue.
    Sybesma JP; Kater L; Borst-Eilers E; de Planque BA; van Soelen T; Tuit G
    Proc Eur Dial Transplant Assoc; 1973; 10(0):406-11. PubMed ID: 4606644
    [No Abstract]   [Full Text] [Related]  

  • 29. Quantitative serologic parameters of purified HL-A antigens.
    Kahan BD; Pellegrino MA; Papermaster BW; Reisfeld RA
    Transplant Proc; 1971 Mar; 3(1):227-30. PubMed ID: 4106313
    [No Abstract]   [Full Text] [Related]  

  • 30. Cross-reactive antigens and HLA matching.
    Scornik JC
    Transplant Proc; 1987 Feb; 19(1 Pt 1):693-5. PubMed ID: 3274845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specificity of mouse cytotoxic T lymphocytes stimulated with either HLA-A and -B or HLA-DR antigens reconstituted into phospholipid vesicles.
    Engelhard VH; Kaufman JF; Strominger JL; Burakoff SJ
    J Exp Med; 1980 Aug; 152(2 Pt 2):54s-64s. PubMed ID: 6157770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA molecule--cytoskeleton associations induced by cross-linking with specific antibodies.
    Hasková V; Ivasková E; Macurová H
    Folia Biol (Praha); 1988; 34(6):372-9. PubMed ID: 3073966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Do we have a sufficient supply of anti-HLA serum? Review of sera produced by the transfusion service 1974-1992].
    Májský A
    Vnitr Lek; 1993 Sep; 39(9):883-6. PubMed ID: 8212642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for homologues of the murine I-A and I-E loci in the rat MHC.
    Shinohara N; Sachs DH
    J Immunol; 1981 Mar; 126(3):934-7. PubMed ID: 6970226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-reactivity of primate alloantigens: absorption of anti-HL-A reactivity from human alloantisera by chimpanzee lymphocytes.
    Ward FE; Seigler HF; Metzgar RS; Reid DM
    Tissue Antigens; 1973; 3(5):389-401. PubMed ID: 4797783
    [No Abstract]   [Full Text] [Related]  

  • 36. Screening of 78 monoclonal antibodies directed against human leukocyte antigens for cross-reactivity with surface markers on canine lymphocytes.
    Chabanne L; Marchal T; Kaplanski C; Fournel C; Magnol JP; Monier JC; Rigal D
    Tissue Antigens; 1994 Mar; 43(3):202-5. PubMed ID: 8091419
    [No Abstract]   [Full Text] [Related]  

  • 37. Cell-mediated cytotoxicity toward human lymphocytes: comparison between in vivo immunization and in vitro sensitization.
    Mawas C; Christen Y; Legrand L; Dausset J
    Transplant Proc; 1973 Dec; 5(4):1691-5. PubMed ID: 4130078
    [No Abstract]   [Full Text] [Related]  

  • 38. Anti-BROC-A1 (anti-H-2s) antibodies cross-react with HLA-A11.
    Iványi P; van Mourik P; de Lange G; Tsuji K; Garrido F
    Transplant Proc; 1981 Dec; 13(4):1958-61. PubMed ID: 6277061
    [No Abstract]   [Full Text] [Related]  

  • 39. Reactions of kidney cells with cytotoxic antisera: possible evidence of kidney-specific antigens.
    Perkins HA; Gantan Z; Siegel S; Howell E; Belzer FO; Kountz SL
    Tissue Antigens; 1975 Apr; 5(2):89-98. PubMed ID: 1093285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Passive enhancement of mouse skin allografts. Specificity of the antiserum for major histocompatibility.
    Staines NA; Guy K; Davies DA
    Transplantation; 1974 Aug; 18(2):192-5. PubMed ID: 4602953
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.